The report provides a detailed analysis essential for establishing a cefazolin production plant. It encompasses all critical aspects necessary for cefazolin production, including the cost of cefazolin production, cefazolin plant cost, cefazolin production costs, and the overall cefazolin production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a cefazolin production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Cefazolin is a widely used antibiotic compound that finds important applications in the pharmaceutical and healthcare industry. It is mainly utilised for the treatment of bacterial infections caused by susceptible organisms, including infections of the skin, bones, joints, respiratory tract, and urinary tract. It is used as a drug in the treatment of skin infections, respiratory tract infections, urinary tract infections, bone infections, and bloodstream infections. It is commonly used in hospitals as a preventive antibiotic before surgeries to reduce the risk of post-operative infections. It is also used in managing bloodstream infections and other serious conditions where quick bacterial control is needed. It is often used in emergency and inpatient care because it is administered through injection for faster results. It is also sometimes used as an ingredient in the production of injectable antibiotic formulations used in clinical care.
The primary factor that drives the market for cefazolin is its application as a preventive antibiotic for surgical prophylaxis, which significantly promotes its demand in the medical and pharmaceutical industries. Its application as a medication in the treatment of urinary tract infections, bone infections, and respiratory tract infections also contributes to its demand in the pharmaceutical industry. Its application as a medication in hospitals and critical care settings to prevent infections before and after surgical procedures further strengthens its demand in the medical sector.
Its demand as an essential drug in modern infections for controlling and preventing bacterial diseases also adds to its market expansion. The increasing prevalence of hospital-acquired infections and the need for effective injectable antibiotics have further supported its rising demand across the healthcare and pharmaceutical sectors. Several crucial factors, such as the cost and availability of core ingredients, regulatory approvals from health authorities, and production compliance with good production practices (GMP), largely impact industrial cefazolin procurement. Other important considerations include improvements in sterile production technology, supplier performance, environmentally responsible practices, and the strength of logistics networks, which further shape its procurement decisions worldwide.
Raw Material for Cefazolin Production
According to the cefazolin production plant project report, the major raw materials for cefazolin production include 7-aminocephalosporanic acid (7-ACA), tetrazolylacetic acid, pivaloyl chloride, and 2-mercapto-5-methyl-1,3,4-thiadiazole.
Production Process of Cefazolin
The extensive cefazolin production cost report consists of the following industrial production process:
- Production via Chemical Synthesis: The production process of cefazolin begins with the reaction of 7-aminocephalosporanic acid (7-ACA) with a mixed anhydride, which is formed by reacting tetrazolylacetic acid with pivaloyl chloride. This step introduces the tetrazolylacetyl side chain at the 7-position. Further, the intermediate is reacted with 2-mercapto-5-methyl-1,3,4-thiadiazole, which replaces the acetoxy group at the 3-position through a substitution reaction. This final modification produces cefazolin, which is then purified to obtain the finished antibiotic compound.
Cefazolin is a first-generation semisynthetic cephalosporin antibiotic widely used for the treatment of bacterial infections and surgical prophylaxis. It appears as white to off-white needle-like crystals that are hygroscopic in nature. The molecular formula of the compound is C14H14N8O4S3, and its molar mass is 454.51 g/mol. It is commercially known by trade names such as Ancef and Kefzol. Its density is approximately 2.01 g/cm³, and its melting point ranges from 198 to 200 degree Celsius. The compound is practically insoluble in water but soluble in dimethylformamide (DMF), pyridine, aqueous acetone, and aqueous ethanol, and slightly soluble in DMSO. It is comparatively unstable and should be protected from heat and light, and it is recommended to store the compound at −20 degree Celsius under an inert atmosphere. The compound is classified as harmful if swallowed, and it is advisable to wear protective clothing, safety glasses, and gloves while handling the substance. Patients with a known history of hypersensitivity to cephalosporins or penicillins should exercise caution, as cross-sensitivity reactions may occur.
